View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Sid Rajeev
  • Sid Rajeev

Smartwatch Momentum Continues with New Launches and Tariff Mitigation ...

Zepp Health Corporation, a global smartwatch maker, delivered strong Q1 2025 results, with 25% YoY shipment growth and 10% revenue increase, fueled by new launches like the Amazfit Active 2 and Bip 6. Despite an EPS dip to -$0.08, Zepp holds its rank as the seventh-largest smartwatch brand. The company is mitigating U.S. tariff risks through strategic shipment planning and Vietnam-based production, while its $179M net working capital dwarfs its $38M market cap, signaling undervaluation. Zepp ant...

Sid Rajeev
  • Sid Rajeev

Navigating Tariffs & Capitalizing on Affordability

Zepp Health Corporation (NYSE: ZEPP) saw a 28% stock rise since November 2024, with Q4-2024 revenue up 40% QoQ, driven by a 29% shipment surge. Despite a negative EPS, the T-Rex 3 and Amazfit Active 2 launches boosted growth. Ranking seventh in global smartwatch sales, Zepp leverages affordability amid tariffs, with $207M in net assets against a $51M market cap, signaling undervaluation.

Sid Rajeev
  • Sid Rajeev

Q3 Disappoints, But Consumer Demand Shifts to Affordable Competitors

This report provides an in-depth analysis of Zepp Health Corporation's (NYSE: ZEPP) Q3-2024 performance, highlighting a 4% QoQ revenue increase but a 49% YoY decline due to lower unit sales and product discontinuations. The report examines the launch of the T-Rex 3 smartwatch, supply chain constraints, and Zepp's competitive positioning in the global smartwatch market. It also discusses management's optimistic Q4 guidance, industry trends, and the valuation discrepancy between Zepp's market cap ...

Sid Rajeev
  • Sid Rajeev

Revenue Dip, Cost-Cutting Success, Eyeing H2 Recovery

Zepp Health Corporation (NYSE: ZEPP) experienced a significant revenue decline in Q2-2024, down 56% year-over-year, missing estimates due to lower-than-expected unit sales and the discontinuation of low-margin products. Despite the drop, cost-cutting measures led to an improvement in EBITDA, though it remained negative. The global smartwatch market also saw a 9% decline in shipments, impacting Zepp’s performance. However, the company is optimistic about a recovery in the second half of the year,...

Sid Rajeev
  • Sid Rajeev

Discover Zepp Health’s Latest Q1 Insights (ZEPP - NYSE)

Zepp Health specializes in smart wearables, providing advanced health tracking and fitness monitoring solutions. Despite a challenging Q1 2024, Zepp Health's strategic decisions and commitment to innovation are setting the stage for a promising year ahead. - Q1 2024 Performance: Revenue down 55% YoY, missing estimates by 7% due to lower unit sales. - Strategic Moves: Halted production of low-margin products, boosting gross profit for self-branded units by 33% YoY. - Market Position: Maintained ...

Sid Rajeev
  • Sid Rajeev

Zepp Health Corporation (NYSE: ZEPP) – Subdued Q1 Outlook / Trading Be...

Fundamental Research Corp has issued a report entitled “Subdued Q1 Outlook / Trading Below Liquid Assets” and dated Mar 20, 2024. The full report is now at FRC TOP PICK

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch